Replies to post #20599 on NorthWest Biotherapeutics Inc (NWBO)

[JSwy17]

OR, what technology they may want to partner with, OR BUY that is BETTER than this;

2 immediate deaths out of 16 patients treated means Juno needs to back off their potency (or dose level), find immune response controls, and/or restrict it to patients that can tolerate the treatment.

I hope they can get past "several" worrisome side effect issues. Particularly Runaway cytokine release syndrome in such a high percentage of patients. Next, they will need to get the cost down from $500,000.00 per patient -- if Citibank's estimate is correct.

Finally, it will be interesting what response they achieve in solid tumor applications. flipper44

[swamprabbit]

supposedly the two deaths were unrelated to car therapy but they do sound suspicious. these patients used in car trials have exhausted every avenue and are weeks away from death. they are all stage four. I lost everything I invested in generation one cancer vaccines. once bitten twice shy but hoping for a different outcome this time around. the only hope for survival in this game is to not put all your eggs in one basket no matter how convinced you are or how appealing it looks.